Morgan Stanley analyst Betsy Graseck maintained a Buy rating on State Street (STT – Research Report) today and set a price target of ...

In a report released today, Kevin Cassidy from Rosenblatt Securities maintained a Buy rating on Marvell (MRVL – Research Report), with a price ...

Despite Q4 earnings hit by transaction costs, CBIZ expects smoother progress and significant growth in 2025. See why I ...

The treasury yield has been moving towards its lowest point in a month following a comment from the Treasury Secretary, Scott ...

We recently published a list of Wall Street’s Top 10 AI Stocks to Watch Right Now. In this article, we are going to take a ...

In a research report to clients March 4, the analyst initiated coverage of CJT with a “Buy” rating and 12-month price target ...

We recently compiled a list of the 10 Worst Performing IT Services Stocks to Buy According to Analysts. In this article, we ...

Worries about stunted growth in FEMSA's OXXO convenience store chain were eased. Click here to read why I maintain FMX stock ...

Cino (NCNO) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock ...

SoundHound AI (NASDAQ:SOUN – Get Free Report)‘s stock had its “buy” rating reiterated by research analysts at HC Wainwright ...

Argus has a "buy" rating and $185 price target for JNJ stock, which closed at $146.64 on Jan. 23. AbbVie is a global pharmaceutical company. Its key drugs include Humira for treating rheumatoid ...

Rated "hold" by Argus with limited 12-month upside. Argus maintains a five-year "buy" rating with no price target. Vertex Pharmaceuticals specializes in developing therapies to treat cystic ...